Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
Xuedong Wang(Harbin Medical University), Soldano Ferrone(Harvard University)
Cited by 18
Related Papers
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
|JNCI Journal of the National Cancer Institute|2010|187
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
|Frontiers in Neuroscience|2021|144
Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4
|Cancer Research|2011|57